Skip to content

Continuous Positive Airway Pressure (CPAP) After Adenotonsillectomy in Children

Sleep-Disordered Breathing and CPAP After Adenotonsillectomy in Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01554527
Enrollment
120
Registered
2012-03-15
Start date
2012-03-31
Completion date
2017-10-29
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Disorder With Hyperactivity, Child Behavior Disorders, Disorders of Excessive Somnolence, Sleep Apnea, Obstructive, Sleep Apnea Syndromes

Keywords

polysomnography, child, continuous positive airway pressure, tonsillectomy, neuropsychological tests, cognition, sleepiness, behavior

Brief summary

Obstructive sleep-disordered breathing (SDB) affects 2-3% of children and may lead to problems with nighttime sleep and daytime behavior, learning, sleepiness, and mood. Adenotonsillectomy (AT) is the second most common surgical procedure in children. It is now performed more often for suspected SDB than for any other indication. However, recent studies indicate that many if not most children still have SDB after AT, and many still have learning or behavioral problems associated with SDB. The goals of this study are: (1) to assess the extent that behavior, cognition, and sleepiness in children can improve with Continuous positive airway pressure (CPAP) treatment after AT, and (2) to identify which patients stand to gain most from post-operative assessment and treatment.

Detailed description

Obstructive sleep-disordered breathing (SDB) affects at least 2-3% of children and may have substantial adverse impact on behavior and cognition. Adenotonsillectomy (AT), the second most common surgical procedure in children, is now performed more often for suspected SDB than for any other indication. However, recent studies among an increasingly obese population now show something alarming: many if not most children still have SDB after AT, and many still suffer from residual neurobehavioral morbidity. Furthermore, the investigators' ongoing, 12-year, NIH-funded research has shown that standard preoperative polysomnographic measures of SDB do not consistently predict post-AT improvement in behavior and cognition. This may arise in part because many children after AT still have SDB, and because linear relationships between standard SDB measures and neurobehavioral morbidity may not exist. Even at subtle levels, SDB may promote significant neurobehavioral morbidity. Some have suggested that polysomnography may be more important after AT than before AT. However, in practice few children receive polysomnography before AT, and even fewer after AT, when continuous positive airway pressure (CPAP) could still provide definitive relief from SDB. Preliminary data from our group suggest that CPAP after AT is well-tolerated by most children and may provide significant benefit. However, virtually no published evidence exists to address critical clinical questions: which children benefit most from CPAP after AT; what role can clinical symptoms or polysomnography play in that determination; and what neurobehavioral gains are achieved by CPAP after AT? The investigators therefore will undertake a highly practical, clinical study with two main goals: (1) to assess the extent that behavior, cognition, and sleepiness in children can improve with CPAP after AT, and (2) to identify which patients stand to gain most from post-operative assessment and treatment. This research will use reversible SDB-related neurobehavioral morbidity as the criteria by which to judge the utility of clinical symptoms and polysomnography in identification of candidates for CPAP after AT.

Interventions

PROCEDURECPAP treatment

6 months of treatment with PAP (CPAP or BPAP)

OTHERNo CPAP treatment

Children randomized to the comparison group will receive routine care

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Michigan Technological University
CollaboratorOTHER
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

1. Children ages 5-12 years old, 2. Scheduled for an adenotonsillectomy for treatment of sleep apnea, 3. Child must provide assent, and 4. Parent or legal guardian must be able to speak and read English, and agree to the study.

Exclusion criteria

1. No siblings of children already enrolled in the study, 2. Children who expect to have another surgery (in addition to AT) during the period of participation in this study, 3. Neurological, psychiatric, or medical conditions, or social factors that may affect test results, prevent children from returning for required study visits, or interfere with the study treatment, or 4. Certain medications that affect sleepiness or alertness, for example: * Stimulants (such as Ritalin, Adderall, or Concerta), * Sleep aides (such as Melatonin, Ambien, or Ativan), or * Sedating medicines (such as Benadryl, Klonopin, Xanax, or Valerian).

Design outcomes

Primary

MeasureTime frameDescription
Change in Behavioral Index After 6 Months of CPAP or No-CPAPassessed as change from baseline to 6 months of CPAP therapy or no-CPAPThe sum of the T-scores of The Conners' Parent Rating Scales (CPRS-R:L, ADHD index) and the Child Behavior Checklist (CBCL, Attention Deficit/Hyperactivity Problems) are used to construct the primary study outcome measure Behavioral Index. Behavioral index is a T score (adjusted for age and gender) with a range of \<10 to \>90 - where higher scores mean worse behavior and lower scores mean better behavior, so a negative change score represents an improvement in behavior. T-scores with a mean of 50 and SD of 10 are computed.

Secondary

MeasureTime frameDescription
Change in Cognition as Shown by NIH Toolbox Composite Scoreassessed as change from baseline to 6 months of CPAP therapy or no-CPAPScores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40 and Maximum value 160. Higher scores are better
Change in Sleepiness as Measured by Epworth Sleepiness Scaleassessed as change from baseline to 6 months of CPAP therapy or no-CPAPEpworth Sleepiness Scale scores range from 0 to 24 where higher scores mean greater sleepiness.
Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)assessed as change from baseline to 6 months of CPAP therapy or no-CPAPMultiple Sleep Latency Test (MSLT) is an objective measure of sleepiness determined by measure of brain waves and other physiological signals over a 30 minute period. This is measured for five 30 minute periods across the day and average latency to sleep for each participant across those times were used to calculate the mean sleep latency. The score is measured in how quickly one would fall asleep, measured in minutes, so a negative number of minutes in the change score means that participants fell asleep more quickly than previously.
Change in Quality of Life as Measured by Peds QLassessed as change from baseline to 6 months of CPAP therapy or no-CPAPPeds-QL is a quality of life symptom measurement with a score range of 0 to 100. Higher scores are better quality of life
CPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently.Starting at 4 months after AT and continuing through 10 months after ATCPAP adherence data will be downloaded from CPAP machines. It is defined for this study as using the CPAP machine for at least an average of 4 hours per night during the last 60 days of the assignment.

Other

MeasureTime frameDescription
Change in Cognition as Measured by Fluid Cognition Scoresassessed as change from baseline to 6 months of CPAP therapy or no-CPAPScores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40, Maximum value 160. Higher scores are better
Change in Cognition After AT as Shown by Academic Achievementassessed as change from baseline to 6 months of CPAP therapy or no-CPAPAcademic achievement mean score is a standardized score with a mean of 100 and SD 15. Minimum value 40 and Maximum value 160. Higher scores are better

Countries

United States

Participant flow

Recruitment details

Of 120 consented, 105 were randomized to CPAP or control. (Of the 15 who weren't randomized, 8 were lost to follow up; the other withdrew for various reasons)

Participants by arm

ArmCount
Control Group (Surgery Only - no CPAP)
The participants who were not assigned to CPAP
34
CPAP After Surgery (Adherent)
Those participants assigned to CPAP who had at least 4 hours of electronically recorded CPAP use per night
38
CPAP After Surgery (Non-adherent)
Those participants assigned CPAP who did not have at least 4 hours of electronically recorded CPAP use per night.
33
Total105

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up004
Overall StudyPhysician Decision001
Overall StudyWithdrawal by Subject103

Baseline characteristics

CharacteristicTotalControl Group (Surgery Only - no CPAP)CPAP After Surgery (Adherent)CPAP After Surgery (Non-adherent)
Academic Achievement Score104.6 units on a scale
STANDARD_DEVIATION 13.1
104.1 units on a scale
STANDARD_DEVIATION 13.4
107.2 units on a scale
STANDARD_DEVIATION 14.6
102.1 units on a scale
STANDARD_DEVIATION 10.7
Age, Continuous8.1 years
STANDARD_DEVIATION 2.1
7.9 years
STANDARD_DEVIATION 2
8.3 years
STANDARD_DEVIATION 2.2
8.0 years
STANDARD_DEVIATION 2
(Apnea-Hypopnea Index (AHI)2.2 events/hour
STANDARD_DEVIATION 1.9
2.4 events/hour
STANDARD_DEVIATION 2
2.2 events/hour
STANDARD_DEVIATION 1.7
2.1 events/hour
STANDARD_DEVIATION 2
Behavioral Index58.5 units on a scale (T-Score)
STANDARD_DEVIATION 12.1
61.6 units on a scale (T-Score)
STANDARD_DEVIATION 13.4
56.5 units on a scale (T-Score)
STANDARD_DEVIATION 11.3
57.8 units on a scale (T-Score)
STANDARD_DEVIATION 11.6
Epworth Sleepiness Scale6.8 units on a scale
STANDARD_DEVIATION 3.9
7.2 units on a scale
STANDARD_DEVIATION 4.6
6.9 units on a scale
STANDARD_DEVIATION 3.9
6.4 units on a scale
STANDARD_DEVIATION 3
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants5 Participants2 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
98 Participants29 Participants36 Participants33 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Fluid Cognition Composite Age Adjusted score95.8 units on a scale
STANDARD_DEVIATION 13.1
97.3 units on a scale
STANDARD_DEVIATION 13.2
96 units on a scale
STANDARD_DEVIATION 14.2
93.9 units on a scale
STANDARD_DEVIATION 11.6
Multiple Sleep Latency Test (MSLT)25.0 minutes
STANDARD_DEVIATION 5.3
24.7 minutes
STANDARD_DEVIATION 6
25.9 minutes
STANDARD_DEVIATION 4.6
24.4 minutes
STANDARD_DEVIATION 5.4
NIH Toolbox Age adjusted composite score95.1 units on a scale
STANDARD_DEVIATION 11.6
95.7 units on a scale
STANDARD_DEVIATION 11.9
96.2 units on a scale
STANDARD_DEVIATION 12.3
93.9 units on a scale
STANDARD_DEVIATION 11.6
Quality of Life78.1 units on a scale
STANDARD_DEVIATION 14.9
78.2 units on a scale
STANDARD_DEVIATION 13.7
78.7 units on a scale
STANDARD_DEVIATION 16
77.3 units on a scale
STANDARD_DEVIATION 17.2
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
3 Participants1 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
14 Participants1 Participants5 Participants8 Participants
Race (NIH/OMB)
More than one race
12 Participants4 Participants3 Participants5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
76 Participants28 Participants29 Participants19 Participants
Region of Enrollment
United States
105 Participants34 Participants38 Participants33 Participants
Sex: Female, Male
Female
50 Participants13 Participants21 Participants16 Participants
Sex: Female, Male
Male
55 Participants21 Participants17 Participants17 Participants
Sleep Related Breathing Disturbances (SBRD) sub-scale of Pediatric Sleep Questionnaire0.35 Ratio
STANDARD_DEVIATION 0.21
0.36 Ratio
STANDARD_DEVIATION 0.24
0.32 Ratio
STANDARD_DEVIATION 0.21
0.37 Ratio
STANDARD_DEVIATION 0.17

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 690 / 360 / 15
other
Total, other adverse events
59 / 6926 / 367 / 15
serious
Total, serious adverse events
6 / 697 / 364 / 15

Outcome results

Primary

Change in Behavioral Index After 6 Months of CPAP or No-CPAP

The sum of the T-scores of The Conners' Parent Rating Scales (CPRS-R:L, ADHD index) and the Child Behavior Checklist (CBCL, Attention Deficit/Hyperactivity Problems) are used to construct the primary study outcome measure Behavioral Index. Behavioral index is a T score (adjusted for age and gender) with a range of \<10 to \>90 - where higher scores mean worse behavior and lower scores mean better behavior, so a negative change score represents an improvement in behavior. T-scores with a mean of 50 and SD of 10 are computed.

Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

Population: Data for two participants in the control group are not available.

ArmMeasureValue (MEAN)Dispersion
Control Group (Surgery Only - no CPAP)Change in Behavioral Index After 6 Months of CPAP or No-CPAP-2.7 T scoreStandard Deviation 5.8
CPAP After Surgery (Non-adherent)Change in Behavioral Index After 6 Months of CPAP or No-CPAP.9 T scoreStandard Deviation 4.8
CPAP After Surgery (Adherent)Change in Behavioral Index After 6 Months of CPAP or No-CPAP-1.2 T scoreStandard Deviation 6.3
Comparison: Intent to treat for controls vs. treatment (adherent/non-adherent)p-value: 0.07t-test, 2 sided
Secondary

Change in Cognition as Shown by NIH Toolbox Composite Score

Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40 and Maximum value 160. Higher scores are better

Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

Population: Lower numbers of participants analyzed are shown here because the tool is not appropriate for younger children

ArmMeasureValue (MEAN)Dispersion
Control Group (Surgery Only - no CPAP)Change in Cognition as Shown by NIH Toolbox Composite Score5.5 score on a scaleStandard Deviation 9.5
CPAP After Surgery (Non-adherent)Change in Cognition as Shown by NIH Toolbox Composite Score2.8 score on a scaleStandard Deviation 9.8
CPAP After Surgery (Adherent)Change in Cognition as Shown by NIH Toolbox Composite Score3.9 score on a scaleStandard Deviation 7.8
Comparison: Intent to treat for controls vs. treatment (adherent/non-adherent)p-value: 0.34t-test, 2 sided
Secondary

Change in Quality of Life as Measured by Peds QL

Peds-QL is a quality of life symptom measurement with a score range of 0 to 100. Higher scores are better quality of life

Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

Population: Data for one participant is not available

ArmMeasureValue (MEAN)Dispersion
Control Group (Surgery Only - no CPAP)Change in Quality of Life as Measured by Peds QL4.1 score on a scaleStandard Deviation 9
CPAP After Surgery (Non-adherent)Change in Quality of Life as Measured by Peds QL0.5 score on a scaleStandard Deviation 10.2
CPAP After Surgery (Adherent)Change in Quality of Life as Measured by Peds QL2.4 score on a scaleStandard Deviation 12.1
Comparison: Intent to treat for controls vs. treatment (adherent/non-adherent)p-value: 0.25t-test, 2 sided
Secondary

Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)

Multiple Sleep Latency Test (MSLT) is an objective measure of sleepiness determined by measure of brain waves and other physiological signals over a 30 minute period. This is measured for five 30 minute periods across the day and average latency to sleep for each participant across those times were used to calculate the mean sleep latency. The score is measured in how quickly one would fall asleep, measured in minutes, so a negative number of minutes in the change score means that participants fell asleep more quickly than previously.

Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

Population: Data for one participant are not available

ArmMeasureValue (MEAN)Dispersion
Control Group (Surgery Only - no CPAP)Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)-1.8 minutesStandard Deviation 4
CPAP After Surgery (Non-adherent)Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)-1.3 minutesStandard Deviation 5.1
CPAP After Surgery (Adherent)Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)-1.1 minutesStandard Deviation 4.3
Comparison: Intent to treat for controls vs. treatment (adherent/non-adherent)p-value: 0.5t-test, 2 sided
Secondary

Change in Sleepiness as Measured by Epworth Sleepiness Scale

Epworth Sleepiness Scale scores range from 0 to 24 where higher scores mean greater sleepiness.

Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

Population: Data for two participants are not available

ArmMeasureValue (MEAN)Dispersion
Control Group (Surgery Only - no CPAP)Change in Sleepiness as Measured by Epworth Sleepiness Scale-1.6 score on a scaleStandard Deviation 3.7
CPAP After Surgery (Non-adherent)Change in Sleepiness as Measured by Epworth Sleepiness Scale-1.0 score on a scaleStandard Deviation 2.2
CPAP After Surgery (Adherent)Change in Sleepiness as Measured by Epworth Sleepiness Scale-1.9 score on a scaleStandard Deviation 3.8
Comparison: Intent to treat for controls vs. treatment (adherent/non-adherent)p-value: 0.93t-test, 2 sided
Secondary

CPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently.

CPAP adherence data will be downloaded from CPAP machines. It is defined for this study as using the CPAP machine for at least an average of 4 hours per night during the last 60 days of the assignment.

Time frame: Starting at 4 months after AT and continuing through 10 months after AT

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Control Group (Surgery Only - no CPAP)CPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently.38 Participants
Other Pre-specified

Change in Cognition After AT as Shown by Academic Achievement

Academic achievement mean score is a standardized score with a mean of 100 and SD 15. Minimum value 40 and Maximum value 160. Higher scores are better

Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

Population: Data from two participants are not available

ArmMeasureValue (MEAN)Dispersion
Control Group (Surgery Only - no CPAP)Change in Cognition After AT as Shown by Academic Achievement-1.0 units on a scaleStandard Deviation 5.6
CPAP After Surgery (Non-adherent)Change in Cognition After AT as Shown by Academic Achievement1.1 units on a scaleStandard Deviation 4.7
CPAP After Surgery (Adherent)Change in Cognition After AT as Shown by Academic Achievement-2.5 units on a scaleStandard Deviation 8.6
Other Pre-specified

Change in Cognition as Measured by Fluid Cognition Scores

Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40, Maximum value 160. Higher scores are better

Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP

Population: Lower numbers are shown here as the tool is not appropriate for younger children

ArmMeasureValue (MEAN)Dispersion
Control Group (Surgery Only - no CPAP)Change in Cognition as Measured by Fluid Cognition Scores6.7 score on a scaleStandard Deviation 12.4
CPAP After Surgery (Non-adherent)Change in Cognition as Measured by Fluid Cognition Scores1.7 score on a scaleStandard Deviation 11.5
CPAP After Surgery (Adherent)Change in Cognition as Measured by Fluid Cognition Scores3.4 score on a scaleStandard Deviation 10.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026